The filamentous meshwork formed by the lamin nucleoskeleton provides a scaffold for the anchoring of highly condensed heterochromatic DNA to the nuclear envelope, thereby establishing the threedimensional architecture of the genome [1] . Insight into the importance of lamins to cellular viability can be gleaned from laminopathies, severe disorders caused by mutations in genes encoding lamins. A cellular consequence of lamin dysfunction in laminopathies is relaxation of heterochromatic DNA [1] . Similarly, we have recently reported the widespread relaxation of heterochromatin in tauopathies [1] : age-related progressive neurodegenerative disorders, including Alzheimer's disease, that are pathologically characterized by aggregates of phosphorylated tau protein in the brain [2, 3] . Here we demonstrate that acquired lamin misregulation though aberrant cytoskeletal-nucleoskeletal coupling promotes relaxation of heterochromatin and neuronal death in an in vivo model of neurodegenerative tauopathy. Genetic manipulation of lamin function significantly modifies neurodegeneration in vivo, demonstrating that lamin pathology plays a causal role in tau-mediated neurotoxicity. We show that lamin dysfunction is conserved in human tauopathy, as super-resolution microscopy reveals a significantly disrupted nuclear lamina in postmortem tissue from human Alzheimer's disease brain. Our study provides strong evidence that tauopathies are neurodegenerative laminopathies and identifies a new pathway mediating neuronal death in currently untreatable human neurodegenerative disorders, including Alzheimer's disease.
RESULTS
The model organism Drosophila provides a genetically tractable platform that can be used to identify and validate molecular mechanisms. In addition, panneuronal expression of transgenic human tau in Drosophila ( Figure S1A ) recapitulates aspects of human tauopathies such as heterochromatin relaxation [4] , DNA damage [5] , activation of the cell cycle in postmitotic neurons [6] , synapse loss [7] , and progressive neurodegeneration [8] . Because pathogenic tau induces heterochromatin relaxation [4] , and the lamin nucleoskeleton regulates chromatin dynamics [1] , we investigated a potential role for lamin dysfunction in tauopathy. We first determined whether lamin levels are altered in the brains of adult Drosophila panneuronally expressing a disease-associated mutant form of human tau [9] , tau R406W .
Like vertebrate B-type lamin, Drosophila ''Lamin'' is expressed in most cells and developmental stages and has a CaaX box that targets it to the nuclear membrane [10] . In 10-day-old tau
R406W
transgenic Drosophila heads, Lamin protein levels were significantly decreased ( Figure 1A ), whereas protein levels of Drosophila A-type lamin, termed ''Lamin C,'' were not affected ( Figure S1B ). Because Lamin C was unchanged in tau
transgenic Drosophila, we focused subsequent studies on the Drosophila B-type lamin. Abnormal nuclear morphology, including invagination of the nuclear envelope, is common in cells from laminopathy patients [11] . Similarly, we observed invaginations of the nuclear envelope in tau R406W transgenic Drosophila. Costaining with elav, a neuron-specific protein, indicated that nuclei harboring invaginations were neuronal ( Figures 1B and 1C ). In addition to decreased Lamin protein levels in tau-transgenic Drosophila brains, morphological changes of the lamin nucleoskeleton suggest that tau causes dysfunction of neuronal Lamin. We next determined whether Lamin invaginations coincide with pathological tau. Tau phosphorylation is a well-characterized pathogenic event in Alzheimer's disease and related tauopathies [12] . 86% of nuclei containing Lamin invaginations in tau
transgenic Drosophila were positive for tau phosphorylated at serine 214, a disease-associated tau phosphoepitope (Figure 1D ). Taken together, these data suggest that pathological tau reduces Lamin protein levels and causes lamin dysfunction by altering the three-dimensional morphology of the lamin nucleoskeleton.
To determine whether Lamin reduction and disorganization are specific to tau R406W versus a general feature of tau pathology, we utilized Drosophila transgenic for human wild-type tau (tau WT ) [8] or a pseudohyperphosphorylated form of human tau (tau E14 ) [13] . [8, 13] . These data suggest that Lamin pathology is a general feature of tau-induced toxicity and is downstream of aberrant tau phosphorylation. Because expression of tau R406W provides a level of toxicity that is well suited for genetic manipulation and biochemical analysis [8] , 10-day-old tau R406W transgenic flies were used in our subsequent experiments and are referred to as tau hereafter for simplicity. We next determined whether Lamin dysfunction plays a causal role in promoting cell death. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) detects DNA fragmentation and has been used to quantify neuronal death in tau-transgenic Drosophila [4, 6, 14] . Further depletion of Lamin levels in neurons of tau-transgenic Drosophila by RNAi-mediated reduction of Lamin significantly increased neuronal death compared to tau expressed alone (Figure 1E ). As an additional control, we measured TUNEL levels in control and tau-transgenic Drosophila with RNAi targeting luciferase ( Figure S1G ). We next determined whether Lamin depletion activates the cell cycle in postmitotic neurons of tau-transgenic flies. Ectopic expression of cell-cycle markers in postmitotic neurons and their coincidence with tau pathology is a well-described feature of tauopathies [15, 16] , and abnormal activation of the cell cycle in neurons can drive apoptosis in tau-transgenic Drosophila [6] . Based on staining with proliferating cell nuclear antigen (PCNA), we found a significant increase in ectopic cell-cycle activation in tau-transgenic Drosophila brains when Lamin was panneuronally depleted via RNAi ( Figure 1F ). RNAi-mediated Lamin reduction enhanced locomotor defects [4] and shortened median lifespan [8] of tau-transgenic Drosophila (Figures S1H and S1I), suggesting that Lamin depletion affects the overall health of tau-transgenic Drosophila. We validated Lamin mRNA knockdown ( Figure S1J ) and Lamin protein knockdown in control and tau-transgenic Drosophila heads (Figures S1K and S1L). RNAi targeted to Lamin did not change total levels of transgenic tau protein ( Figure S1M ). Together, these genetic manipulations are consistent with a causal role for tau-induced lamin dysfunction in driving cell-cycle activation and subsequent apoptotic cell death of postmitotic neurons.
To determine whether Lamin reduction and disorganization are specific to tauopathy versus a general consequence of neurodegeneration, we utilized a Drosophila model of spinocerebellar ataxia type 3 (SCA3) (Machado-Joseph disease) [17] . We did not detect reduced Lamin levels or a disrupted Lamin nucleoskeleton in brains of adult SCA3 model Drosophila (Figures S1N and S1O). As previously reported, we observed loss of Kenyon cells, the projection neurons of the mushroom bodies, in brains of SCA3 model Drosophila [18] ; however, genetic reduction of Lamin did not exacerbate Kenyon cell loss ( Figure S1P ). These data suggest that Lamin reduction and disorganization are not a result of general neurodegeneration.
While knockout of B-type lamins in the mouse forebrain is known to reduce neuronal number [19] , the effects of lamin dysfunction in the adult brain are not well characterized. We thus determined whether Lamin pathology can drive heterochromatin relaxation, DNA damage, cell-cycle activation, and apoptosis in neurons. Because modest reduction of Lamin levels mediated by transgenic RNAi was not toxic in the absence of transgenic human tau expression, whereas null or strong Lamin mutations are reported to be lethal or semilethal [20, 21] [4] . Three of the six genes that we previously reported as most significantly affected by heterochromatin relaxation in tau-transgenic fly heads [4] were also expressed at higher levels in Lam A25 mutant fly heads ( Figure S2D ).
Because low baseline gene expression causes variability in RT-PCR, it is possible that modest increases in gene expression were undetected. DNA damage is a cellular hallmark of tauopathies in both Drosophila and humans [5, 16] and is a known consequence of heterochromatin relaxation [23] . Significantly more neurons of flies expressing transgenic tau or harboring the Lam A25 mutation had DNA damage compared to control (Figure 2D) . In tau-transgenic flies, all nuclei harboring DNA damage also had a lamin invagination ( Figure S2E ), providing further evidence of the strong connection between lamin pathology and DNA damage in adult neurons.
Having established that Lamin dysfunction is sufficient to cause both heterochromatin relaxation and DNA damage in neurons, we next asked whether Lamin pathology induces neuronal cell-cycle activation and apoptosis. Both PCNA ( Figure 2E Figure 2G ) and lifespan ( Figure 2H ), both of which are features of tauopathy [4, 8, 24] . As additional evidence that lamin pathology lies in the pathway of tau-induced neurotoxicity, heterozygous Lam A25 mutation synergizes with transgenic tau in the brain to induce significantly more neurodegeneration ( Figure S2G ) and neuronal cell-cycle activation ( Figure S2H ) than either does alone. Similarly, in the background of heterozygous Lam A25 mutation, transgenic tau causes further heterochromatin relaxation ( Figure S2I ). Together, these experiments provide strong evidence that Lamin dysfunction is upstream of heterochromatin relaxation, DNA damage, neuronal cell-cycle activation, and apoptosis in the pathway of tau-induced neurotoxicity. We next investigated the mechanism by which pathological tau reduces Lamin protein levels and alters its nuclear distribution. In addition to its role as a microtubule-binding protein, tau also binds actin and induces overstabilization and bundling of filamentous actin (F-actin) in tauopathy [25, 26] . Genetically reversing actin overstabilization significantly suppresses tau neurotoxicity [14, 26] , demonstrating that overstabilization of F-actin is a causal event in tau-induced neurodegeneration. Because the actin cytoskeleton has intimate connections to the lamin nucleoskeleton through the nuclear-envelope-spanning linker of nucleoskeleton and cytoskeleton (LINC) complex [27] , we determined whether manipulating levels of F-actin affects the nuclear lamina. In tau-transgenic Drosophila brains, reversing F-actin stabilization by overexpressing gelsolin [14] , an actin-severing protein, significantly increased Lamin protein levels ( Figures 3A and 3B) , strongly supporting the hypothesis that tau-induced actin stabilization drives neurotoxicity by disrupting the nuclear lamina. Gelsolin overexpression significantly decreased the number of neurons harboring disruptions in the nuclear lamina in tau-transgenic Drosophila ( Figure 3C ). In addition, gelsolin overexpression significantly improved locomotion and prolonged the median lifespan of tau-transgenic Drosophila ( Figures S3A and S3B) , consistent with our previous finding that gelsolin overexpression reduces tau-induced apoptosis in Drosophila brains [14] . To further test whether stabilization of F-actin disrupts Lamin levels and localization, we promoted formation of F-actin in neurons by overexpressing WASp (Figure S3C) or the RD domain of spire ( Figure S3D ) [28, 29] in the absence of transgenic tau. Like transgenic expression of human tau, ectopic stabilization of F-actin in neurons significantly decreased Lamin protein levels in the brain (Figures 3D and 3E ). In addition, genetically promoting actin polymerization induced invagination of the nuclear lamina ( Figure 3F ). We observed concentrations of F-actin [30, 31] in close proximity to Lamin invaginations in tau-transgenic flies ( Figures 3G and 3H) , supporting the hypothesis that tau-induced stabilization of actin filaments causes local disruptions of the nuclear lamina. In addition to regulating actin dynamics in the cytoplasm, nuclear gelsolin, WASp, or spire [32] [33] [34] could potentially affect Lamin levels and/or morphology.
Because the LINC complex acts as a physical bridge between the actin cytoskeleton and the lamin nucleoskeleton, we deter- mined whether the LINC complex facilitates F-actin-induced disruption of the lamin nucleoskeleton in tauopathy.
In Drosophila, Lamin binds directly to LINC-complex-component koi, the Drosophila homolog of human SUN1 [35] . Koi traverses the inner nuclear envelope and binds Msp300, the Drosophila homolog of human nesprin, in the perinuclear space. Together, koi and Msp300 span the nuclear envelope, and Msp300 binds F-actin in the cytoplasm [36] (Figure 3I) . Overstabilizing F-actin via transgenic tau or overexpression of WASp or spire RD altered the distribution of neuronal koi.
Whereas koi lined the nuclear envelope in neurons of control brains, we observed a significant increase in koi-positive blebs and focal concentrations of koi along the nuclear envelope in tau-transgenic and WASp-or spire RD -overexpressing neurons ( Figure 3J ). Reducing the interaction between F-actin and the LINC complex by RNAi-mediated reduction of Msp300 (Figure S3E) or a transposable element insertion into Msp300, Msp300 MB00410 [37] , significantly increased Lamin levels in tautransgenic Drosophila brains ( Figure 3K ) and reduced neuronal apoptosis and aberrant cell-cycle activation ( Figures 3L and 3M ). Neither of these suppressors of tau toxicity altered levels of total transgenic tau protein ( Figure S3F ). Collectively, these experiments provide strong support for a model in which tau-induced overstabilization of F-actin disrupts LINC complex organization and reduces lamin levels and localization, which promotes heterochromatin relaxation, subsequent aberrant cell-cycle activation and neurodegeneration in tauopathy. We next investigated lamin in human Alzheimer's disease, the most common tauopathy. Human brains were collected through the autopsy service at Brigham and Women's Hospital and the Massachusetts Alzheimer's Disease Research Center under the appropriate Institutional Review Board. As predicted, we detected a disruption of the nuclear lamina in neurons from Alzheimer's disease brains, where a significant number of neurons harbored invaginations of the nuclear lamina into the deep nuclear interior ( Figure 4A ; Movie S1). Quantitative analysis of lamin B revealed a significant reduction in lamin B protein levels in neurons from brains of patients with Alzheimer's disease versus controls ( Figure 4B ). Lamina-associated protein 2b (LAP2b) also lined the nuclear invaginations, suggesting that invaginations are not restricted to the lamin protein itself ( Figure 4C ). In addition, membrane invaginations were lined with nuclear pores (Figure 4D ), suggesting that inner and outer membranes of the nuclear envelope invaginate and that invaginations are likely filled with cytoplasm. To visualize the interaction between heterochromatin and lamin, we costained neuronal nuclei with lamin and H3K9me2 or HP1a, both of which are altered in Alzheimer's disease brains [4] . Unlike neuronal nuclei from controls, in which we observed formation of typical perinucleolar chromocenters, nuclei from Alzheimer's disease brains did not exhibit chromocenter staining in neurons harboring lamin invaginations ( Figures 4E and 4F) . Finally, we observed that F-actin ( Figure 4G ) and disease-associated phosphotau (Movie S2) lined the nuclear envelope invaginations in neurons from Alzheimer's disease brains, supporting our hypothesis that tau-induced stabilization of F-actin disrupts the lamin nucleoskeleton.
DISCUSSION
Our data suggest that tauopathies are neurodegenerative laminopathies and establish that B-type lamins are required for maintaining genomic architecture, genomic integrity, function, and survival of adult neurons. We find that lamin abnormalities are present in both Drosophila and human tauopathy, emphasizing the clinical relevance of these data. Whereas irregularities in nuclear shape in Alzheimer's disease have been previously reported [38] , our genetic data from tau-transgenic Drosophila suggest that lamin pathology and nuclear envelope invagination are early events that precede heterochromatin relaxation, neuronal cell-cycle activation, and apoptosis. Mechanistically, we show that tau-induced stabilization of F-actin [26] causes LINC complex dysfunction and reduction and disorganization of lamin in neurons, allowing untethering of heterochromatin from the nuclear periphery, subsequent heterochromatin relaxation, DNA damage, cell-cycle activation, and apoptosis. Tauinduced overstabilization of F-actin is also known to disrupt mitochondrial dynamics, causing increased oxidative stress [14] . Because oxidative stress is known to cause DNA damage in the CNS [39] , it is possible that lamin pathology and oxidative stress both contribute to some of the observed phenotypes. Our studies identify cellular mechanisms that are shared between tauopathies and laminopathies and lay the groundwork for exploration of lamin and the LINC complex as novel therapeutic targets for the treatment of tauopathies.
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